A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. - Catimel,G.; Vermorken,J.B.; Clavel,M.; de Mulder,P.; Judson,I.; Sessa,C.; Piccart,M.; Bruntsch,U.; Verweij,J.; Wanders,J.; Franklin,H.; Kaye,S.B. (Ann Oncol, 1994)